Abstract:Abstract Introduction Fusarium species are ubiquitous in the environment and can cause opportunistic infections in burn-injured patients. Patients with larger burns, prolonged lengths of stay, concomitant antimicrobial use and invasive lines are at higher risk for Fusarium infections. Little data exists on clinical characteristics and in vivo antifungal susceptibilities in burn-injured patients. Methods All positive Fusarium species cultures were retrospectively identified between November 2017 to June 2023 at a regional burn center. Demographic, clinical and microbiologic susceptibility data was collected from the electronic medication record. Descriptive statistics were used to describe the cohort. Results A total of 18 patients had positive Fusarium wound cultures during the study period. The average age was 38.4 ± 11.9 years. The average %TBSA was 54.5 ± 23.4 % and R-Baux score of 92.9 ± 29.3. The most common mechanism of injury was thermal burn (17 patients, 94%). This cohort experienced prolonged ICU (68.9 ± 31.9 days) and hospital (73.6 ± 38.2 days) lengths of stay. The average time from burn injury to positive Fusarium cultures was 19.6 ± 9.0 days. Mechanical ventilation was prolonged (46.1 ± 23.3 days). The average central line duration prior to Fusarium infection was 9.8 ± 10.2 days. Susceptibility data was obtained for voriconazole in 15 patients and for amphotericin in 14 patients. For voriconazole, 5/15 tested isolates had an MIC of 4, 1/15 had an MIC of 8, and 9/15 (60%) isolates returned with MIC ≥ 16. A majority (13/14, 93%) of the MICs tested for amphotericin were ≤ 1. Patients were taken to the OR for source control in all cases. Ten of 18 patients with Fusarium positive infections survived to hospital discharge (55%). The most common cause of death was multi-system organ failure and sepsis (88%). Recorded adverse drug events possibly due to voriconazole and posaconazole included transaminitis (4 cases), QTc prolongation (1 case), and hallucinations (1 case). Amphotericin was suspected of contributing to an acute kidney injury in 1 case. Conclusions This case series reports the clinical characteristics and susceptibility data on Fusarium isolates in a burn-injured population. This cohort was critically ill based on the %TBSA, R-Baux score, and high rate of mechanical ventilation. The MIC results obtained for voriconazole demonstrated a majority of isolates with relatively high MIC values ≥ 16. A majority of the MICs for amphotericin were < 1. It is important to note that no established breakpoints exist for Fusarium species and clinical outcomes are dependent on a variety of factors beyond the susceptibility data. Applicability of Research to Practice Empiric double coverage with voriconazole and amphotericin or amphotericin monotherapy should be considered when Fusarium is a suspected primary pathogen.

Identification of Fusarium from a Patient with Fungemia after Multiple Organ Injury.

Experimental Diagnosis and Treatment of Fusarium Solani Infections in Patient with Leukemia

Invasive Fusarium solani infection diagnosed by traditional microbial detection methods and metagenomic next-generation sequencing in a pediatric patient: a case report and literature review

The experimental diagnosis and treatment of patient with Fusarium solani and bacteria infections

Fatal Gastrointestinal Mucormycosis in an Immunocompetent Patient : a Case Report and Review of the Literature

Disseminated Infection by Fusarium Solani in Acute Lymphocytic Leukemia: A Case Report

Fusarium infections. Criteria for the identification of the responsible species

Cutaneous fusariosis by a species of the Fusarium dimerum species complex in a patient with acute myeloblastic leukemia

505 Fusarium Isolates in Burn-injured Patients: Clinical Characteristics and Susceptibility Patterns

Molecular And Maldi-Tof Ms Differentiation And Antifungal Susceptibility Of Prevalent Clinical Fusarium Species In China

Identification and Characterization of Fusarium proliferatum, a New Species of Fungi that Cause Fungal Keratitis

Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology

Identification of clinically important Fusarium spp.

Internet-Accessible DNA Sequence Database for Identifying Fusaria from Human and Animal Infections

Pathogenic spectrum of fungal keratitis and specific identification of Fusarium solani

Fusarium and allied genera from China: species diversity and distribution

Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis

Fungemia Due to Rhodotorula Mucilaginosa:Clinical and Experimental Study

Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study.

Fusariosis in burn patients: a systematic review of case reports

Invasive fusariosis in acute leukaemia patients-An outbreak in the haematology ward